Patent Number: 8,715,680

Title: HLA peptide therapy

Abstract: The invention provides polypeptides derived from a major histocompatibility complex (MHC) class I human leukocyte antigen (HLA), such as HLA-A2, and derivatives or analogues thereof. The polypeptides, derivatives and analogues can be used to treat or prevent allosensitisation, such as the treatment or prevention of allograft rejection.

Inventors: Ball; Simon (Birmingham, GB), Maillere; Bernard (Gif sur Yvette, FR)

Assignee: The University of Birmingham

International Classification: A61K 39/00 (20060101); A61K 38/00 (20060101); A61K 38/04 (20060101); A61K 38/16 (20060101); C07H 21/04 (20060101)

Expiration Date: 5/06/12018